FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202396706> ?p ?o ?g. }

• W3202396706 abstract "Abstract Background Endovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis and need for recurrent revascularization. Over the past years, paclitaxel was the only active drug to inhibit neointimal proliferation which could be processed to an appropriate balloon coating. The purpose of this study is to assess whether efficacy and safety of sirolimus-coated balloon angioplasty is noninferior to paclitaxel-coated balloon angioplasty. Methods This randomized controlled, single-blinded, multicentre, investigator-initiated noninferiority trial aims to enrol a total of 478 participants with symptomatic femoropopliteal artery disease of Rutherford category 2 to 4 due to de novo stenosis or restenosis. After pre-dilation, participants will be allocated in a 1:1 ratio to either sirolimus- or paclitaxel-coated balloon angioplasty. Post-dilation with the drug-coated balloon (DCB) used or standard balloon is mandatory in case ≥ 50%, and optional in case of ≥ 30% residual diameter stenosis. Bailout stenting with bare-metal nitinol stents should be conducted in case of flow-limiting dissection. Primary noninferiority endpoints are primary patency and the composite of all-cause mortality, major target limb amputation, and clinically driven target lesion revascularization at 12 months. Secondary outcomes are clinical and hemodynamic improvement, change in health-related quality of life, and safety throughout 60 months. Discussion Although concerns about long-term safety of paclitaxel-coated devices were not confirmed by recent patient-level data analyses, conflicting evidence contributed to a loss of confidence among patients and physicians. Therefore, sirolimus, known for a broader therapeutic range than paclitaxel, may serve as a welcome alternative. This will be justified if noninferiority of sirolimus-coated balloon angioplasty against the current standard of paclitaxel-coated balloon angioplasty can be demonstrated. Trial registration ClinicalTrials.gov NCT04475783 . Registered on 17 July 2020 EUDAMED No. CIV-20-11-035172, DRKS00022452" @default.
• W3202396706 created "2021-10-11" @default.
• W3202396706 creator A5004153656 @default.
• W3202396706 creator A5006083917 @default.
• W3202396706 creator A5016620644 @default.
• W3202396706 creator A5064529527 @default.
• W3202396706 creator A5082718504 @default.
• W3202396706 creator A5089060771 @default.
• W3202396706 creator A5090699614 @default.
• W3202396706 date "2021-09-28" @default.
• W3202396706 modified "2023-10-16" @default.
• W3202396706 title "Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial" @default.
• W3202396706 cites W122961614 @default.
• W3202396706 cites W1969170437 @default.
• W3202396706 cites W1976760670 @default.
• W3202396706 cites W1977671695 @default.
• W3202396706 cites W1994084703 @default.
• W3202396706 cites W1994867351 @default.
• W3202396706 cites W1999359428 @default.
• W3202396706 cites W2008850799 @default.
• W3202396706 cites W2046256202 @default.
• W3202396706 cites W2065886428 @default.
• W3202396706 cites W2071686284 @default.
• W3202396706 cites W2118501388 @default.
• W3202396706 cites W2132880199 @default.
• W3202396706 cites W2138874526 @default.
• W3202396706 cites W2144985796 @default.
• W3202396706 cites W2606784939 @default.
• W3202396706 cites W2739447339 @default.
• W3202396706 cites W2887033821 @default.
• W3202396706 cites W2894238119 @default.
• W3202396706 cites W2903350476 @default.
• W3202396706 cites W2921975457 @default.
• W3202396706 cites W2950779966 @default.
• W3202396706 cites W2975859535 @default.
• W3202396706 cites W2979692337 @default.
• W3202396706 cites W2980938315 @default.
• W3202396706 cites W3004149066 @default.
• W3202396706 cites W3023289929 @default.
• W3202396706 cites W3043620783 @default.
• W3202396706 cites W3044458877 @default.
• W3202396706 cites W3080079318 @default.
• W3202396706 cites W3111317163 @default.
• W3202396706 cites W63479105 @default.
• W3202396706 cites W78097482 @default.
• W3202396706 doi "https://doi.org/10.1186/s13063-021-05631-9" @default.
• W3202396706 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8480015" @default.
• W3202396706 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34583746" @default.
• W3202396706 hasPublicationYear "2021" @default.
• W3202396706 type Work @default.
• W3202396706 sameAs 3202396706 @default.
• W3202396706 citedByCount "7" @default.
• W3202396706 countsByYear W32023967062022 @default.
• W3202396706 countsByYear W32023967062023 @default.
• W3202396706 crossrefType "journal-article" @default.
• W3202396706 hasAuthorship W3202396706A5004153656 @default.
• W3202396706 hasAuthorship W3202396706A5006083917 @default.
• W3202396706 hasAuthorship W3202396706A5016620644 @default.
• W3202396706 hasAuthorship W3202396706A5064529527 @default.
• W3202396706 hasAuthorship W3202396706A5082718504 @default.
• W3202396706 hasAuthorship W3202396706A5089060771 @default.
• W3202396706 hasAuthorship W3202396706A5090699614 @default.
• W3202396706 hasBestOaLocation W32023967061 @default.
• W3202396706 hasConcept C126322002 @default.
• W3202396706 hasConcept C126838900 @default.
• W3202396706 hasConcept C139059822 @default.
• W3202396706 hasConcept C141071460 @default.
• W3202396706 hasConcept C168563851 @default.
• W3202396706 hasConcept C2778283817 @default.
• W3202396706 hasConcept C2778583881 @default.
• W3202396706 hasConcept C2779313828 @default.
• W3202396706 hasConcept C2779464278 @default.
• W3202396706 hasConcept C2780007028 @default.
• W3202396706 hasConcept C2780326628 @default.
• W3202396706 hasConcept C2781099653 @default.
• W3202396706 hasConcept C500558357 @default.
• W3202396706 hasConcept C71924100 @default.
• W3202396706 hasConceptScore W3202396706C126322002 @default.
• W3202396706 hasConceptScore W3202396706C126838900 @default.
• W3202396706 hasConceptScore W3202396706C139059822 @default.
• W3202396706 hasConceptScore W3202396706C141071460 @default.
• W3202396706 hasConceptScore W3202396706C168563851 @default.
• W3202396706 hasConceptScore W3202396706C2778283817 @default.
• W3202396706 hasConceptScore W3202396706C2778583881 @default.
• W3202396706 hasConceptScore W3202396706C2779313828 @default.
• W3202396706 hasConceptScore W3202396706C2779464278 @default.
• W3202396706 hasConceptScore W3202396706C2780007028 @default.
• W3202396706 hasConceptScore W3202396706C2780326628 @default.
• W3202396706 hasConceptScore W3202396706C2781099653 @default.
• W3202396706 hasConceptScore W3202396706C500558357 @default.
• W3202396706 hasConceptScore W3202396706C71924100 @default.
• W3202396706 hasFunder F4320313941 @default.
• W3202396706 hasIssue "1" @default.
• W3202396706 hasLocation W32023967061 @default.
• W3202396706 hasLocation W32023967062 @default.
• W3202396706 hasLocation W32023967063 @default.
• W3202396706 hasOpenAccess W3202396706 @default.
• W3202396706 hasPrimaryLocation W32023967061 @default.
• W3202396706 hasRelatedWork W1979219809 @default.
• W3202396706 hasRelatedWork W2037870171 @default.

• next